Aurora Cannabis (ACB) Current Deferred Revenue (2017 - 2025)
Aurora Cannabis (ACB) reported Current Deferred Revenue of $1.4 million for Q4 2025, down 38.96% year-over-year from $2.2 million in Q4 2024, and up 31.26% quarter-over-quarter from $1.0 million in Q3 2025.
Aurora Cannabis (ACB) Current Deferred Revenue (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Current Deferred Revenue data on file, last reported at $1.4 million in Q4 2025.
- Current Deferred Revenue for Q4 2025 came in at $1.4 million, down 38.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.4 million (down 38.96% YoY), and the FY2025 annual result was $748488.3, down 40.21% from the prior year.
- Current Deferred Revenue grew to $1.4 million in Q4 2025 per ACB's latest filing, from $1.0 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $5.2 million in Q3 2021 and troughed at $748488.3 in Q1 2025.
- A 5-year average of $2.2 million and a median of $1.8 million in 2022 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2021 and 2023: Current Deferred Revenue soared 221.14% in 2021, then slumped 67.08% in 2023.
- A 5-year view of Current Deferred Revenue shows it stood at $4.4 million in 2021, then slumped by 53.57% to $2.0 million in 2022, then climbed by 26.45% to $2.6 million in 2023, then retreated by 12.39% to $2.2 million in 2024, then tumbled by 38.96% to $1.4 million in 2025.
- Business Quant data shows ACB's Current Deferred Revenue at $1.4 million in Q4 2025, $1.0 million in Q3 2025, and $1.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 748,488.30 |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 2.57 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 2.03 Mn |
| Sep 30, 2022 | 3.05 Mn |
| Jun 30, 2022 | 3.02 Mn |
| Mar 31, 2022 | 3.41 Mn |
| Dec 31, 2021 | 4.37 Mn |
| Sep 30, 2021 | 5.23 Mn |
| Jun 30, 2021 | 3.39 Mn |
| Mar 31, 2021 | 3.23 Mn |